Skip to main content

Advertisement

SpringerLink
Log in

Leukemia

Stem cells, maturation arrest, and differentiation therapy

  • Commentary
  • Published:
Stem Cell Reviews Aims and scope Submit manuscript

Abstract

Human myeloid leukemias provide models of maturation arrest and differentiation therapy of cancer. The genetic lesions of leukemia result in a block of differentiation (maturation arrest) that allows myeloid leukemic cells to continue to proliferate and/or prevents the terminal differentiation and apoptosis seen in normal white blood cells. In chronic myeloid leukemia, the bcr-abl (t9/22) translocation produces a fusion product that is an activated tyrosine kinase resulting in constitutive activation cells at the myelocyte level. This activation may be inhibited by imatinib mesylate (Gleevec™, STI-571), which blocks the binding of ATP to the activated tyrosine kinase, prevents phosphorylation, and allows the leukemic cells to differentiate and undergo apoptosis. In acute promyelocytic leukemia, fusion of the retinoic acid receptor-α with the gene coding for promyeloctyic protein, the PML-RARα (t15:17) translocation, produces a fusion product that blocks the activity of the promyelocytic protein, which is required for formation of the granules of promyelocytes and prevents further differentiation. Retinoic acids bind to the retinoic acid receptor (RARα) component of the fusion product, resulting in degradation of the fusion protein by ubiqutinization. This allows normal PML to participate in granule formation and differentiation of the promyelocytes. In one common type of acute myeloid leukemia, which results in maturation arrest at the myeloid precursor level, there is a mutation of FLT3, a transmembrane tyrosine kinase, which results in constitutive activation of the IL-3 receptor. This may be blocked by agents that inhibit farnesyl transferase. In each of these examples, specific inhibition of the genetically altered activation molecules of the leukemic cells allows the leukemic cells to differentiate and die. Because acute myeloid leukemias usually have mutation of more than one gene, combinations of specific inhibitors that act on the effects of different specific genetic lesions promises to result in more effective and permanent treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pierce GB, Shikes R, Fink LM. Cancer: A Problem of Developmental Biology. Englewood Cliffs, NJ: Prentice-Hall Inc., 1978; p. 242.

    Google Scholar 

  2. Sell S, Pierce GB. Lab Invest 1994;70:6–22.

    PubMed  CAS  Google Scholar 

  3. Sell S. Crit Rev Oncol Hematol 2004;51:1–28.

    PubMed  Google Scholar 

  4. Sherley JL. Stem Cells 2002:20:561–572

    Article  PubMed  Google Scholar 

  5. Pierce GB, Dixon FJ. Cancer 1959;12:573–583.

    Article  PubMed  CAS  Google Scholar 

  6. Pierce GB, Dixon FJ, Verney EL. Lab Invest 1960;9:583–602.

    PubMed  Google Scholar 

  7. Al-Haji M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MR. Proc Natl Acad Sci USA 2003;100:3983–3988.

    Article  CAS  Google Scholar 

  8. O’Sullivan D, Felding-Haberman, B, Proc AACR (Abstract #2068) 2005;46:484.

    Google Scholar 

  9. Hirschmann-Jax C, Foster AE, Wulf GG, et al. Proc Natl Acad Sci USA 2004;101:14228–14233.

    Article  PubMed  CAS  Google Scholar 

  10. Kondo T, Setoguchi T, Taga T. Proc Natl Acad Sci USA 2004;101:781–786.

    Article  PubMed  CAS  Google Scholar 

  11. Nakano T. Trends Immunol 2003;24:589–594.

    Article  PubMed  CAS  Google Scholar 

  12. Reya T, Morrison SJ, Clake MF, Weissman IL. Nature 2004;414:105–111.

    Article  CAS  Google Scholar 

  13. Pappenheim A. Folia Haematolog 1917;21:91–101.

    Google Scholar 

  14. Till JE, McCulloch EA. Radiat Res 1961;14:213–222.

    Article  PubMed  CAS  Google Scholar 

  15. Siminovich L, McCulloch EA, Till JE. J Cell Comp Physiol 1963;62:327–336.

    Article  Google Scholar 

  16. Carnie AM, Lala PK, Osmond DG (eds). Stem Cells of Renewing Cell Populations, New York: Academic Press, 1976.

    Google Scholar 

  17. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. J Exp Med 1996;183:1797–1806.

    Article  PubMed  CAS  Google Scholar 

  18. Weatherall DJ. Brit Med J 1997;314:492–498.

    PubMed  CAS  Google Scholar 

  19. Herzog EL, Chai L, Krause DS. Blood 2003:102:3483–3493.

    Article  PubMed  CAS  Google Scholar 

  20. Krause DS, Theise ND, Collector, MI, et al. Cell 2001;105:369–377.

    Article  PubMed  CAS  Google Scholar 

  21. Sell S. Stem Cell Rev 2005;1:669.

    Google Scholar 

  22. Graf T. Blood 2002;99:3089–3101.

    Article  PubMed  CAS  Google Scholar 

  23. Furth J, Kahn MC. Am J Cancer 1937;31:276–282.

    Google Scholar 

  24. Makino S, Kano K. JNCI 1955;15:165–1181.

    Google Scholar 

  25. Sutherland HJ, Blair A, Zapf RW. Blood 1996;87:4754–4761.

    PubMed  CAS  Google Scholar 

  26. Bonnet D, Dick JE. Nature Med 1997;3:730–737.

    Article  PubMed  CAS  Google Scholar 

  27. Lapidot T, Sirard C, Bormoor J, et al. Nature 1994;367:645–648.

    Article  PubMed  CAS  Google Scholar 

  28. Bhatia M, Bonnet D, Murdoch B, Gan OL, Dick JE. Nature Med 1998;4:1038–1045.

    Article  PubMed  CAS  Google Scholar 

  29. McKenzie SB. Clin Lab Sci 2005;18:28–37, 2005.

    PubMed  Google Scholar 

  30. Passeque E, Jamieson DH, Ailles LI, Weissman IL. Proc Natl Acad Sci USA 2003;100:11842–11849.

    Article  CAS  Google Scholar 

  31. Rowley JD. Semin Hematol 1999;36:59–72.

    PubMed  CAS  Google Scholar 

  32. Schmidt CA, Przybylski GK. Int Rev Immunol 2001;20:107–115.

    PubMed  CAS  Google Scholar 

  33. Pardal R, Clarke MF, Morrison SJ. Nat Rev Cancer 2003;3:895–902.

    Article  PubMed  CAS  Google Scholar 

  34. Baird SM. In: Sell S (ed). Stem Cells Handbook, Totowa, NY: Humana Press, 2003; pp. 163–175.

    Chapter  Google Scholar 

  35. Sen F, Vega F, Mederios LJ. Semin Diagn Pathol 2003;19:973–984.

    Google Scholar 

  36. Gleissner B, Theil E. Expert Rev Mol Diagn 2003;3:339–355.

    Article  PubMed  CAS  Google Scholar 

  37. Cory S, Vaux DL, Strasser A, Harris AW, Adams JM. Cancer Res 1999;59:1686s-1692s.

    Google Scholar 

  38. Nowell PC, Hungerford DA. Science 1960;132:1497–1499.

    Google Scholar 

  39. Randolph TR. Clin Lab Sci 2005;18:38–48.

    PubMed  Google Scholar 

  40. Tefferi A, Dewald GE, Litsow MO, et al. Mayo Clin Proc 2005;80:390–402.

    Article  PubMed  CAS  Google Scholar 

  41. Kharas MG, Furman. Cancer Res 2005;65:2047–2053.

    Article  PubMed  CAS  Google Scholar 

  42. O’Brien S, Tefferi A. Valent. Hematology, San Diego, CA: American Society Hematology Education Program Book, 2004; 146–162.

    Google Scholar 

  43. Randolph TR. Clin Lab Sci 2005;18:49–56.

    PubMed  Google Scholar 

  44. Deninger M, Buchdunger E, Druker BJ. Blood 2005;105:2640–2643.

    Article  CAS  Google Scholar 

  45. Blay JY, LeCesne A, Alberti L, Ray-Coquart I. Bull Cancer 1995;92:E13-E18.

    Google Scholar 

  46. Goldman J. Curr Opin Hematol 2005;12:33–39.

    Article  PubMed  CAS  Google Scholar 

  47. Pulsipher MA. Pediatr Blood Cancer 2004;43:523–533.

    Article  PubMed  Google Scholar 

  48. Stone RM, O’Donnell MR, Sekeres MA. Hematology, San Diego, CA: American Society of Hematology Education Program Book, 2004; pp. 98–117.

    Google Scholar 

  49. Pui C-H, Schrappe M, Riveiro RC, Neimeyer CM. Hematology, San Diego, CA: American Society of Hematology Education Program Book, 2004; pp 118–145. 2004.

    Google Scholar 

  50. Ziegler DS, Pozza DL, Waters KD, Marshall GM. Medial J Austr 2005;182:78–81.

    Google Scholar 

  51. Gupta V, Chum K, Yi QL, et al. Cancer 2005;103:2082–2090.

    Article  PubMed  Google Scholar 

  52. Jourdan E, Rigal-Huguet F, Marit G, et al. Br J Haematol 2005;129:402–410.

    Article  CAS  Google Scholar 

  53. Woods WG, Neudorf S, Gold S, et al. Blood 2001;97:56–62.

    Article  PubMed  CAS  Google Scholar 

  54. Creutzig U, Ritter J, Zimmerman, M, et al. J Clin Oncol 2001;19:2705–2713.

    PubMed  CAS  Google Scholar 

  55. Loeb DM, Bowers DC, Civin CI, Friedman AD. Med Pediart Oncol 2001;37:365–371.

    Article  CAS  Google Scholar 

  56. Anak S, Saribeyoglu ET, Bilgen H, et al. Pediatr Blood Cancer 2005;44:654–659.

    Article  PubMed  Google Scholar 

  57. Rowley JD. Leukemia 2000;14:513–517.

    Article  PubMed  CAS  Google Scholar 

  58. Seeler JS, Dehean A. Curr Opin Genet Dev 1999;9:362–367.

    Article  PubMed  CAS  Google Scholar 

  59. Zhong S, Salomoni P, Pandolifi PP. Nat Cell Biol 2000;2:E85-E90.

    Article  PubMed  CAS  Google Scholar 

  60. Pitha-Rowe I, Petty WJ, Kitareewan S, Dmitrovsky E. Leukemia 2003;17:1723–1730.

    Article  PubMed  CAS  Google Scholar 

  61. Melnick A, Licht JD. Blood 1999;99:3167–3215.

    Google Scholar 

  62. Segalla S, Rinaldi L, Kilstrup-Nielsen, C, et al. Mol Cell Biol 2003;23:8795–8808.

    Article  PubMed  CAS  Google Scholar 

  63. Alcalay M, Meani N, Gelmetti V, et al. J Clin Invest 2003;112:1751–1761.

    Article  PubMed  CAS  Google Scholar 

  64. Dragnev KH, Petty WJ, Dmitrovsky, E. Cancer Biol Ther 2003;2:S150–156.

    PubMed  CAS  Google Scholar 

  65. Warrell RP Jr, Frankel SR, Miller WH Jr, et al. N Eng J Med 1991;324:1385–1393.

    Article  Google Scholar 

  66. Camacho LH. J Biol Regul Homeost Agents 2003;17:98–114.

    PubMed  CAS  Google Scholar 

  67. Ohno R, Asou N, Ohnishi K. Leukemia 2003;17:1454–1463.

    Article  PubMed  CAS  Google Scholar 

  68. Parmar S, Tallman MS. Expert Opin Pharmacother 2003;4:1379–1392.

    PubMed  CAS  Google Scholar 

  69. Tallman MS, Andersen JW, Schiffer CA, et al. Blood 2002; 100:4298–4302.

    Article  PubMed  CAS  Google Scholar 

  70. Freemantle SJ, Spinella MJ, Dmitrovsky E. Oncogene 2003; 22:7305–7315.

    Article  PubMed  CAS  Google Scholar 

  71. Gallagher RE. Leukemia 2002;16:1940–1958.

    Article  PubMed  CAS  Google Scholar 

  72. Marill J, Idres N, Capron CC, Nguyen E, Chabot GG. Curr Drug Metab 2003;4:1–10.

    Article  PubMed  CAS  Google Scholar 

  73. Mann KK, Rephaeli A, Colosino Al, et al. Mol Cancer Res 2003;1:903–912.

    PubMed  CAS  Google Scholar 

  74. Silverman LR, Demalos EP, Peterson BL, et al. J Clin Oncol 2002;20:2429–2440.

    Article  PubMed  CAS  Google Scholar 

  75. Pilatrino C, Cilloni D, Messa E, et al. Cancer 2005;104:101–109.

    Article  PubMed  CAS  Google Scholar 

  76. Feldman EJ. Curr Hematol Rep 2004;4:186–190.

    Google Scholar 

  77. Lancet JE, Gojo I, Gotlib J, et al. Blood 2003;102:176.

    Article  CAS  Google Scholar 

  78. Levis M. Curr Opin Hematol 2005;12:55–61.

    Article  PubMed  CAS  Google Scholar 

  79. Robinson LJ, Xue J, Corey SJ. Exp Hematol 2005;33:469–479.

    Article  PubMed  CAS  Google Scholar 

  80. Ono R, Nakajima H, Ozaki K, et al. J Clin Invest 2005;115:919–929.

    Article  PubMed  CAS  Google Scholar 

  81. Gilliand DG, Griffin JD. Blood 2002;100:1332–1342.

    Google Scholar 

  82. Clark JJ, Smith FO, Arceci RJ, et al. Curr Opin Hematol 2003;10:31–39.

    Article  PubMed  CAS  Google Scholar 

  83. Arceci RJ, Sande J, Lange B, et al. Blood 2005;106:1183–1188.

    Article  PubMed  CAS  Google Scholar 

  84. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Cell Prolif 2003;36:59–72.

    Article  PubMed  CAS  Google Scholar 

  85. Singh SK, Clarke ID, Terasaki M, et al. Cancer Res 2003;63:5821–5828.

    PubMed  CAS  Google Scholar 

  86. Pierce GB. The cancer cell and its control by the embryo. Am J Pathol 1983;113:117–124.

    PubMed  CAS  Google Scholar 

  87. Spira AI, Carducci MA. Curr Opin Pharmacol 2003;3:338–343.

    Article  PubMed  CAS  Google Scholar 

  88. Strickland S, Madavi V. Cell 1978;15:393.

    Article  PubMed  CAS  Google Scholar 

  89. Ross JS, Schenkein DP, Pietrusko R, et al. Am J Clin Pathol 2004;122:598–609.

    Article  PubMed  CAS  Google Scholar 

  90. Chalandon Y, Schwaller J. Haematologica 2005;90:949–968.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. New York State Department of Health, Wadsworth Center and Ordway Research Institute, Empire State Plaza, 12201, Albany, NY

    Stewart Sell MD

Authors
  1. Stewart Sell MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stewart Sell MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sell, S. Leukemia. Stem Cell Rev 1, 197–205 (2005). https://doi.org/10.1385/SCR:1:3:197

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/SCR:1:3:197

Keywords

Search

Navigation